Skip to main content
Top
Published in: Gastric Cancer 1/2012

01-01-2012 | Editorial

Screening and minimally invasive treatment for gastric cancer are important challenges in elderly patients

Author: Osamu Hosokawa

Published in: Gastric Cancer | Issue 1/2012

Login to get access

Excerpt

The aging of the population in Japan outweighs that in all other countries, with Japan having the highest proportion of elderly people. The average life expectancy of men ranks second behind that of Iceland and the average life expectancy of women is the highest in the world. In 2006, the Ministry of Health, Labour and Welfare announced that the number of elderly Japanese people over 80 years old was about 6,700,000. The ratio of people 80 years or older to the total population in Japan recently overtook the ratios in Italy and Sweden to become the highest in the world. Therefore, Japanese are among the longest-living ethnic groups in the world, but they do not live forever. Human beings die of disease but they don’t die of getting old. Cancer, heart disease, cerebrovascular disease, and pneumonia are the top four causes of death in elderly people in Japan. In 2006, the Japanese Cancer Registry [1] estimated that the number of people over 80 years old affected by gastric cancer was 26,121 (Table 1). The Cancer Registry estimated that the numbers of patients affected by malignant disease in the generation of people over 80 years old were: 23,585 with large-bowel cancer, 23,423 with lung cancer, 8,689 with liver cancer, 8,191 with gallbladder and bile duct cancers, 7,679 with pancreatic cancer, 5,119 with cancer of the urinary bladder, and 4,008 with malignant lymphoma.
Table 1
Gastric cancer incidence and death according to age in Japan (2006)
Age (years)
10–19
20–29
30–39
40–49
50–59
60–69
70–79
≥80
Number of affected patients
12
218
1,301
4,238
16,418
29,068
39,535
26,121
Number of dead patients
8
67
409
1,152
4,962
9,788
16,272
17,753
Proportion of dead patients to affected patients (%)
67
31
31
27
30
34
41
68
Literature
1.
go back to reference Matsuda T, Marugame T, Kamo KI, Katanoda K, Ajiki W, Sobue T. Cancer incidence and incidence rates in Japan: based on data from 12 population-based cancer registries in the monitoring of cancer incidence in Japan (MCIJ) project. JJCO. 2011;41:139–47.PubMed Matsuda T, Marugame T, Kamo KI, Katanoda K, Ajiki W, Sobue T. Cancer incidence and incidence rates in Japan: based on data from 12 population-based cancer registries in the monitoring of cancer incidence in Japan (MCIJ) project. JJCO. 2011;41:139–47.PubMed
2.
go back to reference Abe N, Gotoda T, Hirosawa T, Hoteya S, Ichido K, Ida Y, Imaeda H, Ishiii E, Kokawa A, Kusano C, Maehata T, Ono S, Takeuchi H, Sugiyama M, Takahashi S. Multicenter study of the long-term outcomes of endoscopic submucosal dissection for early cancer in patients 80 years of age or older. Gastric Cancer. 2011;14. Abe N, Gotoda T, Hirosawa T, Hoteya S, Ichido K, Ida Y, Imaeda H, Ishiii E, Kokawa A, Kusano C, Maehata T, Ono S, Takeuchi H, Sugiyama M, Takahashi S. Multicenter study of the long-term outcomes of endoscopic submucosal dissection for early cancer in patients 80 years of age or older. Gastric Cancer. 2011;14.
3.
go back to reference Hosokawa O, Shimbo T, Matsuda K, Miyanaga T. Effectiveness of opportunistic endoscopic screening for gastric cancer compared with organized X-ray screening. J Gastroenterol Cancer Screen. 2011. Hosokawa O, Shimbo T, Matsuda K, Miyanaga T. Effectiveness of opportunistic endoscopic screening for gastric cancer compared with organized X-ray screening. J Gastroenterol Cancer Screen. 2011.
Metadata
Title
Screening and minimally invasive treatment for gastric cancer are important challenges in elderly patients
Author
Osamu Hosokawa
Publication date
01-01-2012
Publisher
Springer Japan
Published in
Gastric Cancer / Issue 1/2012
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-011-0120-7

Other articles of this Issue 1/2012

Gastric Cancer 1/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.